RecruitingNCT03668327

Preterm Birth Cohort Study in Guangzhou

Sponsor

Guangzhou Women and Children's Medical Center

Enrollment

5,000 participants

Start Date

Feb 1, 2012

Study Type

OBSERVATIONAL

Conditions

Host and Microbiome Immune Development Preterm Birth Neurodevelopment

Summary

The Preterm Birth Cohort Study in Guangzhou (PBCSG) aims to explore the impact of genetic and environmental factors including life styles on preterm birth, to examine the interaction effect between these factors, and to follow up the short-term and long-term outcomes of preterm childrens.

Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with host and microbiome, immune development, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.